CBLN1 and metabolic dysfunction-associated steatohepatitis: Cer d18:1/16:0 (Fig. 3h and Additional file 1: Table S3A) and Cer d18:1/18:0 (Additional file 1: Table S3A) increased in WT1 and WT2 NASH liver.